AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Authors
Keywords
-
Journal
npj Vaccines
Volume 3, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1038/s41541-018-0076-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine
- (2018) Sarah M. Tete et al. VACCINE
- The Pathway to a Universal Influenza Vaccine
- (2017) Catharine I. Paules et al. IMMUNITY
- Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China
- (2017) Fuchun Zhang et al. JOURNAL OF INFECTION
- Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses
- (2017) Donald M. Carter et al. JOURNAL OF VIROLOGY
- In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
- (2017) Troy C. Sutton et al. JOURNAL OF VIROLOGY
- Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series
- (2017) Xiling Wang et al. LANCET INFECTIOUS DISEASES
- A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses
- (2017) Chenguang Shen et al. Science Translational Medicine
- A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines
- (2017) Kinnera E. Chada et al. VACCINE
- Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
- (2017) Henning Jacobsen et al. mBio
- Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
- (2016) Anuradha Madan et al. JOURNAL OF INFECTIOUS DISEASES
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
- (2016) Donald M. Carter et al. JOURNAL OF VIROLOGY
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- (2016) Matthew J. Memoli et al. mBio
- Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
- (2016) Jin Gao et al. Jove-Journal of Visualized Experiments
- Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination
- (2016) J. D. Galson et al. Scientific Reports
- Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
- (2015) Lisa A. Jackson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Immune history profoundly affects broadly protective B cell responses to influenza
- (2015) Sarah F. Andrews et al. Science Translational Medicine
- Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults
- (2014) Paul Gillard et al. BMC INFECTIOUS DISEASES
- Antibody-Dependent Effector Functions Against HIV Decline in Subjects Receiving Antiretroviral Therapy
- (2014) V. Madhavi et al. JOURNAL OF INFECTIOUS DISEASES
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children
- (2014) Mary Dawn T. Co et al. VIRAL IMMUNOLOGY
- An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- (2013) Gerald Nakamura et al. Cell Host & Microbe
- Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies
- (2013) S. Jegaskanda et al. JOURNAL OF IMMUNOLOGY
- Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
- (2013) H. Wan et al. JOURNAL OF VIROLOGY
- Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease
- (2013) S. Khurana et al. Science Translational Medicine
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies
- (2012) S. Verma et al. JOURNAL OF VIROLOGY
- Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody
- (2012) A. G. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
- (2011) Joanne M. Langley et al. JOURNAL OF INFECTIOUS DISEASES
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
- (2011) M. R. Sandbulte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults
- (2010) I. Leroux-Roels et al. Clinical and Vaccine Immunology
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
- (2010) Davide Corti et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
- (2010) Joanne M. Langley et al. JOURNAL OF INFECTIOUS DISEASES
- Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets
- (2010) S. Khurana et al. JOURNAL OF VIROLOGY
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
- (2009) Matthew R. Sandbulte et al. Influenza and Other Respiratory Viruses
- Pre‐ and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
- (2009) Wouter Koudstaal et al. JOURNAL OF INFECTIOUS DISEASES
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
- (2009) Isabel Leroux-Roels et al. VACCINE
- Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
- (2009) Surender Khurana et al. PLOS MEDICINE
- Vaccines against epidemic and pandemic influenza
- (2008) Mary Hoelscher et al. Expert Opinion on Drug Delivery
- Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
- (2008) Lance C Jennings et al. LANCET INFECTIOUS DISEASES
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started